Explore Our Network

Alira Health is a global consulting and clinical services company that aims to humanize healthcare and life sciences through innovative technologies and expert guidance. They focus on improving patient outcomes by integrating patient voices into the development of treatments and enhancing care quality across the healthcare ecosystem.

Athena GTX is dedicated to advancing wireless, mobile, patient-worn monitoring solutions for both military and civilian markets. The company focuses on connecting patients and providers through state-of-the-art medical and communication technology, developed and produced in Iowa. Athena GTX aims to enhance patient outcomes by integrating innovative wireless technology with reliable devices, supporting first responders and medical professionals in various challenging environments.

Axiom Management Solutions is a veteran-owned business offering consulting and service support across all stages of medical device development. Axiom's core philosophy: Early-stage medtech innovators deserve to own their development journey without the burden of heavy overhead or restrictive partnerships. Axiom empowers developers to bring their vision to life with precision, flexibility and expert support. The company specializes in helping innovators navigate regulatory requirements, develop prototypes, establish quality management systems, and take medical devices from concept to commercialization.

BioBridge Global is a nonprofit organization dedicated to saving and enhancing lives through the healing power of human cells and tissue. It operates a family of nonprofits including South Texas Blood & Tissue, QualTex Laboratories, GenCure, and The Blood & Tissue Center Foundation. The organization provides lifesaving therapies to patients and supports advances in advanced therapies, focusing on blood, cell, and tissue products, testing services, and the development of new therapies.

BioPharma Connections is an independent, woman-owned consulting firm founded in San Francisco in 2007, providing strategic business development, technical operations, regulatory, product development, and commercialization support to the life sciences industry. Serving pharmaceutical, biotechnology, medical device, and diagnostic companies globally, the firm specializes in facilitating connections between organizations, service providers, CROs, CDMOs, and investors—guiding clients from concept to commercialization, with deep expertise in regulatory compliance, emerging technologies, and diverse therapeutic areas.

BioTechnique® is a full-service Contract Research Development and Manufacturing Organization (CRDMO) specializing in sterile injectable fill-finish services. With a commitment to quality and innovation, BioTechnique® aims to enhance healthcare outcomes worldwide by providing high-quality life-saving products and maintaining the highest standards in pharmaceutical manufacturing.

Blue Goat Cyber provides cybersecurity solutions specifically for medical devices and digital health products, supporting all phases from design and regulatory submission through postmarket management. The company's services emphasize compliance with FDA, EU, and international standards such as ISO 14971, IEC 81001-5-1, and Section 524B, offering Secure Product Development Frameworks, comprehensive penetration testing, risk management, threat modeling, SBOM management, coordinated vulnerability disclosure, and postmarket monitoring. Blue Goat Cyber aims to ensure manufacturers are not only submission-ready but also equipped for ongoing regulatory and procurement demands from hospitals and global regulators.

Brinter is a pioneering US-based MedTech firm focused on revolutionizing tissue engineering through the development of 3D bioprinted biocomposite regenerative implants, known as BioMods™, which aim to restore damaged tissue and replace conventional implants, launching in orthopedics/tendons and ligaments. The company driven by a team of visionary entrepreneurs and leading bioscientists and engineers.

CA Analytical Testing Services is an FDA inspected contract laboratory and drug development partner providing integrated analytical, microbiological, formulation, and CMC support across the product lifecycle. We can integrate directly into development programs to provide analytical method development, microbiological support, formulation and characterization activities, and problem-solving throughout early- and late-stage development. Beyond laboratory testing, CA Analytical can support broader drug and medical device programs through CDMO selection and qualification, technology transfer, third-party quality and manufacturing oversight, regulatory support, QC release testing, and stability programs. Our team can function as an extension of a sponsor's internal development and quality organization, helping coordinate technical activities across multiple external partners. CA Analytical is also building an internal drug product portfolio that includes small-molecule and liposomal formulations. We are particularly interested in partnering with organizations developing novel or alternative drug-delivery technologies that can be combined with existing or emerging therapeutics to improve delivery, durability, usability, and ultimately advance medicines toward clinical application.

CellBios is a biotechnology company specializing in the design, development, and manufacturing of single-use bioprocessing and medical device solutions for healthcare, biotechnology, and regenerative medicine sectors. The company operates GMP and ISO-certified cleanroom facilities, offering a comprehensive portfolio of cryopreservation products, bioreactors, fluid management systems, advanced packaging, and specialty devices. By leveraging expertise in extrusion, molding, assembly, sterilization, quality control, and regulatory compliance, CellBios provides customized, scalable solutions to support blood transfusion, cell and gene therapy, biologics manufacturing, and clinical workflows.

Cepheid is a global leader in molecular diagnostics, dedicated to improving healthcare by developing, manufacturing, and marketing automated, easy-to-use molecular systems and tests. Their mission is to provide rapid, accurate, and actionable genetic testing for a wide range of infectious diseases, oncology, and human genetics. Cepheid's flagship GeneXpert System delivers scalable, sample-to-answer PCR testing for institutions of any size, supporting both centralized and decentralized care. The company is committed to expanding access to high-quality diagnostics worldwide, supporting public health initiatives, driving innovation in molecular testing, and advancing sustainability and responsible business practices.

Clinical Research Strategies (CRS) is a Pittsburgh-based contract research organization and executive management consultancy dedicated to improving the performance of start-up and mid-size life sciences companies. With a focus on instilling fiscal discipline and reducing risks in clinical development, corporate affairs, and quality assurance programs, CRS provides tailored consulting and staffing solutions to navigate the complexities of regulatory pathways and ensure successful product launches. CRS is also committed to leveraging advancements in artificial intelligence and machine learning to enhance clinical research and regulatory processes.

CMC Pharmaceuticals, Inc. provides integrated services supporting drug development for small molecule therapeutics and medical countermeasures. The company offers comprehensive solutions for formulation and process development, analytical method validation, stability and compatibility testing, manufacturing oversight, and regulatory support across all phases—including specialized expertise in handling highly potent compounds and government MCM (Medical Countermeasure) programs. In-house laboratories and robust regulatory systems ensure submission-ready, compliant data, addressing the safety and operational requirements of both commercial and defense sectors.

Cook MyoSite, a subsidiary of Cook Group, has been advancing human muscle cell technology since 2002. Operating under ISO 9001:2015-certified quality standards, we specialize in primary human skeletal muscle-derived cells and fibro-adipogenic progenitors sourced from healthy donors and individuals with neuromuscular, metabolic, and rare disorders. Our offerings include custom cell procurement, specialized media formulations, and contract manufacturing services—supporting both academic research and clinical development in regenerative medicine. Beyond research tools, Cook MyoSite is pioneering autologous muscle-derived cell therapies. Our investigational product, iltamiocel, is currently in a Phase III clinical trial for fecal incontinence, demonstrating our commitment to translating cell-based science into real-world solutions. With expertise in GMP manufacturing, analytical testing, and tailored partnerships, we empower collaborators to accelerate innovation in musculoskeletal and neuromuscular health worldwide.

Corscience is a German-based medical technology development and manufacturing provider specializing in advanced solutions for defibrillation, patient monitoring, and vital sign acquisition. The company supports OEMs and medtech startups internationally with expertise across R&D, regulatory affairs (including MDR and FDA compliance), quality management, lifecycle management, and technical consulting. Their track record includes the delivery of complex, safety-critical systems and robust integration of electronic, software, and mechanical components in medical devices.

Creare is a leading innovator in technology and product development, specializing in engineering research and development services. With over 50 years of experience, Creare combines sophisticated analytical methods with creative engineering to solve complex challenges across various sectors, including biomedical systems, cryogenics, fluid dynamics, and advanced manufacturing. The company is dedicated to delivering innovative solutions that enhance product functionality, reduce costs, and accelerate time-to-market for its clients. Technology commercialization has been a key part of Creare’s mission since its founding in 1961, leading to significant revenue generation through licensing and spin-offs.

DesignPlex Biomedical specializes in the prototyping, design development, and contract manufacturing of medical devices. The company is dedicated to improving patient outcomes through innovative medical solutions, focusing on quality and collaboration with clients to bring their ideas to life.

Ease Healthcare (a registered DBA of MPS Medical, Inc.) is committed to advancing next-generation military medicine by accelerating access to clinically validated diagnostic tools, monitoring devices, and health and wellness technologies. As a trusted commercialization partner and distributor, the company empowers providers, organizations, and individuals with advanced solutions that support early detection, timely intervention, and improved health outcomes in both civilian and military settings. With a mission to make cutting-edge science and technology accessible to all, Ease Healthcare focuses on addressing critical health challenges such as 02 delivery, cancer, and cardiovascular disease —areas that directly impact force readiness and resilience. The company’s vision is to break barriers in healthcare by delivering innovative medical solutions that are affordable, accessible, and simple to use, regardless of economic or geographic limitations. In addition to bringing transformative technologies to market, Ease Healthcare provides turnkey services for medical device manufacturing and distribution, guiding partners from product development through regulatory compliance and successful deployment. By combining technical expertise with a dedication to accessibility, Ease Healthcare supports the Department of Defense’s priorities in preparing and protecting service members with next-generation healthcare solutions.

Emergent BioSolutions is dedicated to developing, manufacturing, and delivering medical countermeasures that address public health threats. With a mission to protect and enhance life, the company focuses on innovative vaccines and therapeutics to combat critical health challenges, including the ongoing opioid crisis.

EmergingDx is dedicated to inventing, developing, and commercializing emerging technologies and products aimed at improving the quality of the human condition while positively impacting the environment and society. The company comprises a diverse team of world-class scientists, engineers, product designers, and business leaders with a proven track record of innovation and successful technology transition.

Gel4Med is a commercial-stage company pioneering the use of smart, bioinspired materials to address major challenges in medicine. Founded out of Harvard Innovation Labs, Gel4Med leverages its proprietary Smart Materials Platform™ (SMP™) to develop advanced therapeutics and devices, with a mission to enhance health outcomes and access for all patients. The company is committed to creating novel biomaterials that improve regenerative medicine and surgical solutions, and has achieved significant milestones including FDA clearance for its lead wound care product, G4Derm™ Plus.